Back to Agenda
Regulatory Science Dialogue
Session Chair(s)
Hugo Hurts
Chair HMA Brexit Task Force; Executive Director
Medicines Evaluation Board (MEB), Netherlands
Regulatory science involves various stakeholders, each with different interests and responsibilities. The ‘Expert Meeting’-dialogue model of the Regulatory Science Network Netherlands promotes learning through dialogue between these stakeholders.
Learning Objective : Participants should be informed about the ‘Expert Meeting’-dialogue model applied to bring together the relevant stakeholders in the Netherlands to advance the field of regulatory science. Participants should be able to differentiate the various stakeholders and their own responsibilities and interests to compose a sound regulatory strategy.
Speaker(s)
One Decade of Dialogue Experience in the Public-private European Regulatory Science Space (e.g. IMI, RSNN)
Pieter Stolk, PharmD, PhD
University Medical Centre Utrecht, Netherlands
Project Manager
Informed Dialogue and Stakeholder Interests in Regulatory Science
Sini Eskola, MPharm, MS, MSc
EFPIA - European Federation of Pharmaceutical Industries and Associations, Belgium
Director Regulatory Strategy
How Dialogue Improves Regulatory Pathways
Peter Mol, PharmD, PhD
MEB, Netherlands
CHMP member, NL
Gerrit Borchard
University of Geneva, Switzerland
Panelist
Carla Torre
Ordem dos Farmacêuticos, Portugal
Secretary General
Panelist
Robin Verjans, PhD, MS
Lygature, Netherlands
Program Manager
Have an account?